The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1b study of HS-10241 combined with almonertinib in pre-treated advanced non-small cell lung cancer (NSCLC) harboring EGFR mutation.
 
Xiaorong Dong
No Relationships to Disclose
 
Jianhua Chen
No Relationships to Disclose
 
Yan Yu
No Relationships to Disclose
 
Jie Hu
No Relationships to Disclose
 
Xingya Li
No Relationships to Disclose
 
Ying Cheng
No Relationships to Disclose
 
Wenxiu Yao
No Relationships to Disclose
 
Yanping Hu
No Relationships to Disclose
 
Qiming Wang
Consulting or Advisory Role - Hansoh Pharma
Research Funding - Hansoh Pharma (Inst)
 
Junguo Lu
Research Funding - Akeso Biopharma (Inst); Hansoh (Inst); Shanghai Henlius Biotech (Inst)
 
Wei Zheng
No Relationships to Disclose
 
Xinmin Yu
Research Funding - BeiGene; BMS; Hansoh; Innovent Biologics; MSD
 
Peng Zhang
No Relationships to Disclose
 
Zhuang Yu
No Relationships to Disclose
 
Hongying Wei
Employment - Hansoh Pharma
Stock and Other Ownership Interests - Hansoh Pharma
 
Chuan Li
Employment - Hansoh Pharma
Stock and Other Ownership Interests - Hansoh Pharma
 
Qiqi Huang
Employment - Hansoh Pharma
Stock and Other Ownership Interests - Hansoh Pharma
 
Mengyuan Tao
Employment - Hansoh Pharma
 
Qiong Wu
Employment - Hansoh Pharma
Leadership - Hansoh Pharma
Stock and Other Ownership Interests - Hansoh Pharma
 
Shun Lu
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; GenomiCare; Hutchison MediPharma; InventisBio Co. Ltd; Menarini; Pfizer; Roche; Simcere; Yuhan; Zai Lab
Speakers' Bureau - AstraZeneca; Hansoh Pharma; Hengrui Therapeutics; Roche
Research Funding - AstraZeneca (Inst); BeiGene (Inst); BMS (Inst); Hansoh (Inst); Hengrui Therapeutics (Inst); Hutchison MediPharma (Inst); Lilly Suzhou Pharmaceutical Co. (Inst); Roche (Inst)